Date Title Description PDF
23 Nov 2022 On business and financial situation The Company releases the presentation related to its strategy update because of its 2022 Capital Markets Day   Download
04 Nov 2022 On business and financial situation The Company releases the first nine months 2022 financial results presentation Download
04 Nov 2022 On business and financial situation The Company releases the press release related to the first nine months of 2022 financial results Download
15 Mar 2022 On significant placements in financial instruments Bestinver announces details of an accelerated book building process of approximately 5% of the share capital of Laboratorios Farmacéuticos Rovi, S.A. Download
14 Mar 2022 On significant placements in financial instruments Bestinver announces the beginning of an accelerated book building process approximately 5% of the share capital of Laboratorios Farmacéuticos Rovi, S.A. Download

Pages

Date Title Description PDF
11 May 2022 On business and financial situation The Company releases the first quarter 2022 financial results presentation Download
11 May 2022 Announcement of general shareholders’ meeting Rovi releases the information related to its 2022 General Shareholders Meeting Download
11 May 2022 On Corporate Governance The Company informs about the appointment of a new member in its Board of Directors       Download
05 Apr 2022 Liquidity and counterparty agreements The Company communicates that it has entered into a liquidity agreement with Bestinver S.V., S.A.  Download
29 Mar 2022 Share buy-back , stabilisation and treasury stock programme Share Buyback Program: transactions conducted on 28 March 2022 and end of the share buyback program Download

Pages

Date Title Description PDF
08 Oct 2018 Share capital increases and reductions Information on the registration in the Commercial Registry of Madrid of the notarial deed regarding the capital increase Download
05 Oct 2018 Buy-back programmes, stabilisation and treasury stock Information about the possibility that Jefferies International Limited carries out stabilisation transactions within the framework of the capital increase excluding pre-emptive subscription rights of the existing shareholders of Laboratorios Farmacéuticos Rovi, S.A. Download
04 Oct 2018 Share capital increases and reductions Directors’ Report and Independent Expert Report related to capital increase excluding preferential subscription rights Download
04 Oct 2018 Liquidity contracts and specialists The Company informs that has temporarily suspended liquidity agreement with JB Capital Markets, Sociedad de Valores, S.A.U. Download
04 Oct 2018 Share capital increases and reductions Information on price fixing and outcome of the private placement related to capital increase addressed to institutional investors, excluding preferential subscription rights Download

Pages